Spineart’s ROMEO2 PAD Posterior Axial Device receives FDA approval

Spineart’s ROMEO2 PAD Posterior Axial Device received 510(k) clearance from the U. S. Food and Drug Administration.

Advertisement

The device is a posterior non-pedicle supplemental fixation device intended for use as an adjunct to fusion in the lumbar spine. It features two plates and a central core and 30 degrees of plate poliaxiality.

 

Spineart is a privately held medical device company focused on the fields of minimally invasive surgery, motion preservation, fusion, biologics and fracture treatment.

More articles on devices:

Alphatec Spine comes out ahead in patent infringement case after rule change
Conventus Orthopaedics raises $24M funding — 5 things to know
5 quick facts on Orchid Orthopedic Solutions’ $2.1M facility expansion

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spine

Advertisement

Comments are closed.